SC-2001

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameSC-2001
Drug Alias NameSC-2001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInduced myeloid leukemia cell differentiation protein Mcl-1 inhibitors
TargetsInduced myeloid leukemia cell differentiation protein Mcl-1
Therapy Area/IndicationsCarcinoma, Hepatocellular
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNational Yang-Ming University, Kaohsiung, Taiwan, Roc
China Registration ClassN/A

Develop Information

Active CompaniesNational Yang-Ming University, Kaohsiung, Taiwan, Roc
Inactive CompaniesN/A
Active IndicationsCarcinoma, Hepatocellular
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A